PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

New Mental Health Outreach Funding for Homeless

NHS England has announced that towns with high rates of homelessness are set for investment in specialist mental health care, as part of services for rough sleepers across the country.

Currently more than half of everyone sleeping on the streets lives with a mental health problem, while those affected by homelessness die, on average, around 30 years earlier than the general population.

The new initiative, formed of NHS-led teams will bring together doctors, nurses and other clinicians to co-ordinate treatment and support with other local organisations including councils.

In each area, outreach teams – comprising NHS and local authority staff – will identify rough sleepers in need of help, support them to access a GP and then on to the new expert psychiatric help.

At least 20 areas with high levels of rough sleeping will be expected to have set up new teams by 2023/24 as part of a wider national roll-out – backed by £30 million as part of the NHS Long Term Plan.

“While the NHS cannot solve homelessness on its own, it is working hard to make sure rough sleepers have easy access to services that are built and designed around their needs – putting an end to the revolving door of trauma care,” commented Claire Murdoch, NHS national director for mental health.

She continued, “Many rough sleepers have been through incredibly traumatic experiences which can cause mental ill health or exacerbate problems – often impacting on the type of support they need and this is about stopping people slipping through the net.”

The first wave of funding is worth almost £12 million over the next five years and will be used to build and scale up comprehensive services across Birmingham, Brighton, Hull, Luton and more.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026